Page last updated: 2024-12-07

3,4-dihydro-3,4-dibromo-6-bromomethylcoumarin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,4-dihydro-3,4-dibromo-6-bromomethylcoumarin: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID128035
SCHEMBL ID3365215
MeSH IDM0107025

Synonyms (10)

Synonym
dhdbbmc
50465-97-9
3,4-dibromo-6-(bromomethyl)chroman-2-one
SCHEMBL3365215
3,4-dibromo-6-(bromomethyl)-3,4-dihydrochromen-2-one
dihydrocoumarin i
3,4-dihydro-3,4-dibromo-6-bromomethylcoumarin
2h-1-benzopyran-2-one, 3,4-dibromo-6-(bromomethyl)-3,4-dihydro-
3,4-dibromo-6-(bromomethyl)-3,4-dihydro-2h-1-benzopyran-2-one
DTXSID80964696

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"Toxicogenomics, based on the temporal effects of drugs on gene expression, is able to predict toxic effects earlier than traditional technologies by analyzing changes in genomic biomarkers that could precede subsequent protein translation and initiation of histological organ damage."( High-density real-time PCR-based in vivo toxicogenomic screen to predict organ-specific toxicity.
Bito, T; Fabian, G; Farago, N; Feher, LZ; Katona, RL; Kitajka, K; Kulin, S; Nagy, LI; Puskas, LG; Tiszlavicz, L; Tubak, V, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (20.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's7 (70.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.97 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index5.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]